Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia

Leukemia Research
Z XiaM Wetzler

Abstract

Signal transducer and activator of transcription (STAT) proteins are implicated in the control of cell survival, proliferation and differentiation in response to hematopoietic cytokines. C-terminally truncated STAT isoforms (STATbeta), as opposed to the full length form (STATalpha), have a competitive or even transdominant negative effect on gene induction mediated by the STAT pathway. We have previously demonstrated that while constitutively active STAT proteins were detected in ten of 36 (28%) for STAT3 and eight of 36 (22%) for STAT5 in pretreatment samples from newly diagnosed acute myeloid leukemia (AML) patients, a significantly larger fraction of samples [21 of 27 (78%)] expressed STATbeta proteins. To determine whether STATbeta expression was maintained or increased after relapse in AML, we compared STAT activity and isoform expression at diagnosis and at relapse in 17 patients. In this selected group, constitutively active STAT3 was detected in 13 of 17 (76%) AML samples at diagnosis but was detected in only four of these patients at relapse. Constitutively active STAT5 was detected in three of 17 (18%) AML samples at diagnosis; but only two at relapse. In contrast, STATbeta protein expression was observed in 12 of the...Continue Reading

References

Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·T S SchaeferD Nathans
Mar 15, 1994·Statistics in Medicine·J H Ellenberg
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·S TakemotoG Franchini
Aug 24, 1999·Cell·J F BrombergJ E Darnell
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y WangH Baumann
Sep 10, 1999·The Journal of Biological Chemistry·C LeeC Schindler

❮ Previous
Next ❯

Citations

May 5, 2001·Leukemia Research·R L Ilaria
Apr 24, 2007·The Biochemical Journal·Haydeé L RamosWendy T Watford
Apr 11, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ben X WangEleanor N Fish
Dec 21, 2004·European Journal of Biochemistry·Lisa Hendry, Susan John
Dec 14, 2002·Blood·Mustafa BenekliMeir Wetzler
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mustafa BenekliMeir Wetzler
Apr 18, 2009·Srpski arhiv za celokupno lekarstvo·Gordana Konjević
Dec 31, 2015·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Aradhana Rani, John J Murphy
Mar 6, 2007·The Journal of Allergy and Clinical Immunology·Weiguo Chen, Gurjit K Khurana Hershey
Mar 27, 2007·Biochemical and Biophysical Research Communications·Abdoreza Davoodi-SemiromiMichael Clare-Salzler
May 7, 2004·European Journal of Haematology·Magdalena Baśkiewicz-Masiuk, Bogusław Machaliński
Apr 20, 2004·European Journal of Haematology·Sergio Gutiérrez-CastellanosCarlos Riebeling-Navarro
Apr 1, 2012·JAK-STAT·Michal Bar-NatanDavid A Frank
Sep 1, 2009·Biochimica Et Biophysica Acta·Yanhong MaYuxun Wang
Jun 30, 2004·Journal of Molecular Biology·A V IvanovaM I Lerman
Aug 3, 2006·Journal of Cellular Physiology·Itamar Barash
Jan 12, 2007·Molecular BioSystems·Cheh Peng Lim, Xinmin Cao
Oct 22, 2003·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ruta NavakauskieneKarl-Eric Magnusson
Feb 16, 2007·The Biochemical Journal·Björn SchusterSusan John
Nov 7, 2014·Expert Review of Hematology·Øystein BruserudHåkon Reikvam
May 12, 2018·International Journal of Oncology·Yin ShiXia Li
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Melanie A ShermanMelissa A Brown
Jul 5, 2019·Blood Advances·Petra AignerDagmar Stoiber
Aug 28, 2021·Biomedicines·Bernhard MoserDagmar Stoiber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.